Additionally, ChIP assays determined that FEZF1-AS1 could simultaneously recruit EZH2 and LSD1 to p57 promoter regions and repress their transcription, which promoted the progression of LAD. This evidence concerns the gene EZH2 and leukocyte adhesion deficiency.